FDA Commissioner Dr. Marty Makary tells CBS News' Norah O'Donnell in an exclusive interview why the agency decided to drop decades-old "black box" warnings on many hormone therapy drugs used for ...

FDA nonmedical wearable health data devices providing general health info will not face regulation, clarifying guidance for ...

More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new ...

Since President Donald Trump took office, the FDA has lost about 20 percent of its staff through reduction-in-force efforts.

“Powerful” new treatments for various types of cancer and neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and ALS, will likely get rolled out within the next few years, Food and Drug ...